Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
BKK:AMARC's Return-on-Tangible-Equity is ranked better than 91.14% of 2382
companies
in the Hardware industry
Industry Median: 5.43
vs BKK:AMARC: 27.51
Asia Medical and Agricultural Laboratory and Research Center PCL (BKK:AMARC) Return-on-Tangible-Equity Explanation
Return-on-Tangible-Equity measures the rate of return on the ownership interest (shareholder's tangible equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' tangible equity (shareholders equity minus intangibles). Return-on-Tangible-Equity shows how well a company uses investment funds to generate earnings growth. Return-on-Tangible-Equitys between 15% and 20% are considered desirable.
Be Aware
Net Income is used.
Because a company can increase its Return-on-Tangible-Equity by having more financial leverage, it is important to watch the leverage ratio when investing in high Return-on-Tangible-Equity companies. Like Return-on-Tangible-Asset, Return-on-Tangible-Equity is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.
Asset light businesses require very few assets to generate very high earnings. Their Return-on-Tangible-Equitys can be extremely high.
Asia Medical and Agricultural Laboratory and Research Center PCL Return-on-Tangible-Equity Related Terms
Asia Medical and Agricultural Laboratory and Research Center PCL Return-on-Tangible-Equity Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Asia Medical and Agricultural Laboratory and Research Center PCL Return-on-Tangible-Equity Chart
Asia Medical and Agricultural Laboratory and Research Center PCL Annual Data
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Asia Medical and Agricultural Laboratory and Research Center PCL Return-on-Tangible-Equity vs Hardware Industry
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual Return-on-Tangible-Equity, the net income of the last fiscal year and the average total shareholder tangible equity over the fiscal year are used. In calculating the quarterly data,
the net income data used here is four times the quarterly (Mar. 2026) net income data.
Return-on-Tangible-Equity is displayed in the 10-year financial page.
What does a Return-on-Tangible-Equity of 15.53% mean?
Asia Medical and Agricultural Laboratory and Research Center PCL (BKK:AMARC) has a Return-on-Tangible-Equity of 15.53% as of Mar. 2026. Return on tangible equity is the ratio of current-period net income to average two-period tangible equity. View historical data on Asia Medical and Agricultural Laboratory and Research Center PCL and its competitors. This is 42% above median its historical median of 10.90. Over the past decade, Asia Medical and Agricultural Laboratory and Research Center PCL's Return-on-Tangible-Equity has ranged from 1.89 to 29.42. According to the industry distribution chart, Asia Medical and Agricultural Laboratory and Research Center PCL ranks #211 out of 2382 companies in the Hardware industry, placing it in the top 8.9%.
Is Asia Medical and Agricultural Laboratory and Research Center PCL's Return-on-Tangible-Equity too high?
Asia Medical and Agricultural Laboratory and Research Center PCL's current Return-on-Tangible-Equity of 15.53% is 42% above median its 10-year median of 10.90. Over the past 10 years, this metric has ranged from a low of 1.89 to a high of 29.42. The Hardware industry median Return-on-Tangible-Equity is 5.43. Asia Medical and Agricultural Laboratory and Research Center PCL's value of 15.53% is 186% above this industry median. Based on the distribution chart, Asia Medical and Agricultural Laboratory and Research Center PCL ranks #211 out of 2382 companies in the Hardware industry, which is in the top quartile — a strong position relative to peers. Overall, Asia Medical and Agricultural Laboratory and Research Center PCL has a GF Score™ of 91/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Asia Medical and Agricultural Laboratory and Research Center PCL's Return-on-Tangible-Equity compare to COHR and KEYS?
According to the Hardware industry distribution chart, Asia Medical and Agricultural Laboratory and Research Center PCL ranks #211 out of 2382 companies for Return-on-Tangible-Equity. This places Asia Medical and Agricultural Laboratory and Research Center PCL in the top 9% of its industry — outperforming the majority of peers. The industry median Return-on-Tangible-Equity is 5.43. Asia Medical and Agricultural Laboratory and Research Center PCL's value of 15.53% is 186% above this benchmark. Historically, Asia Medical and Agricultural Laboratory and Research Center PCL's own Return-on-Tangible-Equity has ranged from 1.89 to 29.42 over the past decade. While the company's 10-year median is 10.90 vs. the industry median of 5.43, Asia Medical and Agricultural Laboratory and Research Center PCL has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Return-on-Tangible-Equity for a Hardware company?
The median Return-on-Tangible-Equity among Hardware companies is 5.43, based on 2,382 companies in the industry. Companies in the top quartile (top 25%) have a Return-on-Tangible-Equity significantly above this median, while those in the bottom quartile fall well below. However, Return-on-Tangible-Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Asia Medical and Agricultural Laboratory and Research Center PCL's current Return-on-Tangible-Equity of 15.53% is 186% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Return-on-Tangible-Equity mean?
A high Return-on-Tangible-Equity can signal that a stock is expensive relative to its fundamentals. Return on tangible equity is the ratio of current-period net income to average two-period tangible equity. View historical data on Asia Medical and Agricultural Laboratory and Research Center PCL and its competitors. For the Hardware industry, the median Return-on-Tangible-Equity is 5.43 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Asia Medical and Agricultural Laboratory and Research Center PCL's current Return-on-Tangible-Equity is 15.53%, which is 42% above median its own 10-year median of 10.90. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Asia Medical and Agricultural Laboratory and Research Center PCL stock overvalued right now?
Based on GuruFocus' analysis, Asia Medical and Agricultural Laboratory and Research Center PCL (BKK:AMARC) is currently considered Modestly Overvalued. The stock's GF Value™ is ฿2.61, compared to a current price of ฿2.92 — trading 11.9% above its estimated fair value. The current Return-on-Tangible-Equity is 15.53%, which is 42% above median its 10-year median of 10.90 and 186% above the Hardware industry median of 5.43. Asia Medical and Agricultural Laboratory and Research Center PCL's overall GF Score™ is 91/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Return-on-Tangible-Equity calculated?
Return-on-Tangible-Equity is calculated from a company's financial statements. For Asia Medical and Agricultural Laboratory and Research Center PCL (BKK:AMARC), the current Return-on-Tangible-Equity is 15.53% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Asia Medical and Agricultural Laboratory and Research Center PCL (BKK:AMARC) Overvalued in 2026?
Based on GuruFocus' analysis, Asia Medical and Agricultural Laboratory and Research Center PCL stock appears to be overvalued.
The current stock price of ฿2.92 is trading 11.9% above its estimated GF Value™ of ฿2.61.
GuruFocus considers Asia Medical and Agricultural Laboratory and Research Center PCL to be Modestly Overvalued.
Key valuation signals for BKK:AMARC:
Return-on-Tangible-Equity: 15.53% (42% above median its 10-year median of 10.90)
GF Value™: ฿2.61 vs. price of ฿2.92 (11.9% above fair value)
Industry Position: 186% above the Hardware median (#211 of 2382)
No single metric tells the full story. See the BKK:AMARC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Asia Medical and Agricultural Laboratory and Research Center PCL is engaged in providing comprehensive scientific services for the agriculture, food, pharmaceutical and environment sectors including testing, calibration, inspection and certification according to international quality standards. The company geographically operates only in Thailand.
91GF Score
Get the complete analysis for BKK:AMARC
Return-on-Tangible-Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BKK:AMARC has been successfully added to your 
